During the past decade, Colo-Proctology Center Matsushima Clinic conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Colo-Proctology Center Matsushima Clinic" are "Crohn's Disease" (3 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Colo-Proctology Center Matsushima Clinic" in a lesser frequency.

Most popular intervention types in "Colo-Proctology Center Matsushima Clinic" are "Drug" (2 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ontamalimab" (2 trials), "Placebo" (2 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Colo-Proctology Center Matsushima Clinic" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Colo-Proctology Center Matsushima Clinic". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Colo-Proctology Center Matsushima Clinic, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Colo-Proctology Center Matsushima Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".